‘Substantial clinical benefit’ and ‘substantial clinical worsening’ cut-off of Vitiligo Impact Scale (VIS)-22 change scores

Vishal Gupta,Neha Taneja,Hem Chandra Sati,Vishnubhatla Sreenivas,M Ramam
DOI: https://doi.org/10.1093/bjd/ljae178
IF: 11.113
2024-04-22
British Journal of Dermatology
Abstract:Patient-centric outcome measures focus on clinically meaningful change in various aspects of disease, including severity, quality-of-life, and psychological distress. The minimal important change (MIC) is a commonly used threshold of patient-reported outcome measures, representing the smallest difference that is considered significant by the patient and/or physician. However, it has been suggested that MIC is too low a bar for determining treatment success, and alternative thresholds such as substantial clinical benefit (SCB) and patient acceptable symptom state (PASS) may be preferred.
dermatology
What problem does this paper attempt to address?